nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.117	0.265	CbGbCtD
Rifabutin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0936	0.212	CbGbCtD
Rifabutin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0613	0.139	CbGbCtD
Rifabutin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.057	0.129	CbGbCtD
Rifabutin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0458	0.104	CbGbCtD
Rifabutin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0262	0.0593	CbGbCtD
Rifabutin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.024	0.0544	CbGbCtD
Rifabutin—HSP90AA1—pons—peripheral nervous system neoplasm	0.0209	0.289	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0164	0.0371	CbGbCtD
Rifabutin—HSP90AA1—ganglion—peripheral nervous system neoplasm	0.0107	0.148	CbGeAlD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00971	0.0627	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00862	0.0556	CbGpPWpGaD
Rifabutin—HSP90B1—trigeminal ganglion—peripheral nervous system neoplasm	0.00718	0.0995	CbGeAlD
Rifabutin—HSP90B1—parotid gland—peripheral nervous system neoplasm	0.00678	0.0939	CbGeAlD
Rifabutin—HSP90B1—brainstem—peripheral nervous system neoplasm	0.00636	0.0881	CbGeAlD
Rifabutin—HSP90AA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00525	0.0728	CbGeAlD
Rifabutin—HSP90AA1—parotid gland—peripheral nervous system neoplasm	0.00495	0.0687	CbGeAlD
Rifabutin—HSP90AA1—EBV LMP1 signaling—IFNB1—peripheral nervous system neoplasm	0.00466	0.0301	CbGpPWpGaD
Rifabutin—HSP90AA1—brainstem—peripheral nervous system neoplasm	0.00465	0.0644	CbGeAlD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00401	0.0259	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00379	0.0245	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00343	0.0221	CbGpPWpGaD
Rifabutin—HSP90B1—cerebellum—peripheral nervous system neoplasm	0.00313	0.0434	CbGeAlD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—AURKA—peripheral nervous system neoplasm	0.00295	0.019	CbGpPWpGaD
Rifabutin—HSP90AA1—ErbB receptor signaling network—ERBB2—peripheral nervous system neoplasm	0.00292	0.0188	CbGpPWpGaD
Rifabutin—HSP90AA1—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00284	0.0184	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00279	0.018	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00256	0.0165	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—CDKN2A—peripheral nervous system neoplasm	0.00253	0.0163	CbGpPWpGaD
Rifabutin—HSP90AA1—cerebellum—peripheral nervous system neoplasm	0.00229	0.0318	CbGeAlD
Rifabutin—HSP90AA1—VEGFR1 specific signals—PTPN11—peripheral nervous system neoplasm	0.00218	0.0141	CbGpPWpGaD
Rifabutin—HSP90AA1—eNOS activation—AKT1—peripheral nervous system neoplasm	0.00216	0.0139	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—MYC—peripheral nervous system neoplasm	0.00212	0.0137	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00209	0.0135	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—EED—peripheral nervous system neoplasm	0.00189	0.0122	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	0.00188	0.0121	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—NRAS—peripheral nervous system neoplasm	0.00184	0.0119	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—PTPN11—peripheral nervous system neoplasm	0.00179	0.0116	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CD55—peripheral nervous system neoplasm	0.00179	0.0116	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.00175	0.0113	CbGpPWpGaD
Rifabutin—HSP90AA1—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—peripheral nervous system neoplasm	0.00171	0.0111	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.00157	0.0102	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	0.00151	0.00973	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—AKT1—peripheral nervous system neoplasm	0.00147	0.00951	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00146	0.00945	CbGpPWpGaD
Rifabutin—HSP90AA1—G2/M Transition—AURKA—peripheral nervous system neoplasm	0.00141	0.00911	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—peripheral nervous system neoplasm	0.00141	0.00907	CbGpPWpGaD
Rifabutin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.0014	0.00903	CbGpPWpGaD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	0.00139	0.00899	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—HRAS—peripheral nervous system neoplasm	0.00134	0.00868	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.00131	0.00843	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.00124	0.00804	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.00122	0.00787	CbGpPWpGaD
Rifabutin—HSP90AA1—Semaphorin interactions—MET—peripheral nervous system neoplasm	0.00121	0.00778	CbGpPWpGaD
Rifabutin—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00119	0.00766	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism of nitric oxide—AKT1—peripheral nervous system neoplasm	0.00119	0.00766	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—PTPN11—peripheral nervous system neoplasm	0.00117	0.00756	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—PTPN11—peripheral nervous system neoplasm	0.0011	0.00711	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.00107	0.0069	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00104	0.00674	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD55—peripheral nervous system neoplasm	0.00104	0.00673	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00104	0.00673	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—MYC—peripheral nervous system neoplasm	0.001	0.00648	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events—NRAS—peripheral nervous system neoplasm	0.000922	0.00595	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000906	0.00585	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000906	0.00585	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.00089	0.00575	CbGpPWpGaD
Rifabutin—HSP90AA1—Semaphorin interactions—ERBB2—peripheral nervous system neoplasm	0.000881	0.00569	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFR2 mediated vascular permeability—AKT1—peripheral nervous system neoplasm	0.00087	0.00562	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFR1 specific signals—AKT1—peripheral nervous system neoplasm	0.000846	0.00546	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000844	0.00545	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000843	0.00544	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000836	0.00539	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.00082	0.00529	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD34—peripheral nervous system neoplasm	0.000791	0.0051	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—PTPN11—peripheral nervous system neoplasm	0.000767	0.00495	CbGpPWpGaD
Rifabutin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000766	0.00494	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000761	0.00491	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.000731	0.00472	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events mediated by Akt—AKT1—peripheral nervous system neoplasm	0.000728	0.0047	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—PTPN11—peripheral nervous system neoplasm	0.000724	0.00467	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000715	0.00461	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000699	0.00451	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—AKT1—peripheral nervous system neoplasm	0.000696	0.00449	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events—HRAS—peripheral nervous system neoplasm	0.000674	0.00435	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000673	0.00434	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—NCAM1—peripheral nervous system neoplasm	0.000672	0.00434	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000663	0.00428	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	0.000661	0.00427	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000621	0.00401	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000621	0.00401	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.000617	0.00398	CbGpPWpGaD
Rifabutin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000602	0.00182	CcSEcCtD
Rifabutin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000602	0.00182	CcSEcCtD
Rifabutin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000602	0.00182	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000598	0.0018	CcSEcCtD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—AKT1—peripheral nervous system neoplasm	0.000595	0.00384	CbGpPWpGaD
Rifabutin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000594	0.00179	CcSEcCtD
Rifabutin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000594	0.00179	CcSEcCtD
Rifabutin—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000593	0.00179	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00178	CcSEcCtD
Rifabutin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000591	0.00178	CcSEcCtD
Rifabutin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.00176	CcSEcCtD
Rifabutin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00058	0.00175	CcSEcCtD
Rifabutin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000573	0.00173	CcSEcCtD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00057	0.00368	CbGpPWpGaD
Rifabutin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00171	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000567	0.00171	CcSEcCtD
Rifabutin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000566	0.00171	CcSEcCtD
Rifabutin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.00171	CcSEcCtD
Rifabutin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000561	0.00169	CcSEcCtD
Rifabutin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000561	0.00169	CcSEcCtD
Rifabutin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.00169	CcSEcCtD
Rifabutin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000557	0.00168	CcSEcCtD
Rifabutin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000554	0.00167	CcSEcCtD
Rifabutin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000551	0.00166	CcSEcCtD
Rifabutin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00166	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—PTPN11—peripheral nervous system neoplasm	0.000547	0.00353	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000547	0.00353	CbGpPWpGaD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.00165	CcSEcCtD
Rifabutin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000547	0.00165	CcSEcCtD
Rifabutin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000547	0.00165	CcSEcCtD
Rifabutin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000545	0.00164	CcSEcCtD
Rifabutin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000543	0.00164	CcSEcCtD
Rifabutin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000541	0.00163	CcSEcCtD
Rifabutin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000541	0.00163	CcSEcCtD
Rifabutin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00163	CcSEcCtD
Rifabutin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00054	0.00163	CcSEcCtD
Rifabutin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000539	0.00163	CcSEcCtD
Rifabutin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000539	0.00163	CcSEcCtD
Rifabutin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000533	0.00161	CcSEcCtD
Rifabutin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000532	0.00161	CcSEcCtD
Rifabutin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00053	0.0016	CcSEcCtD
Rifabutin—HSP90B1—Immune System—IFNB1—peripheral nervous system neoplasm	0.000527	0.0034	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000526	0.00159	CcSEcCtD
Rifabutin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000526	0.00159	CcSEcCtD
Rifabutin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00158	CcSEcCtD
Rifabutin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.00158	CcSEcCtD
Rifabutin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000521	0.00157	CcSEcCtD
Rifabutin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000521	0.00157	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.00052	0.00336	CbGpPWpGaD
Rifabutin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.00156	CcSEcCtD
Rifabutin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.00155	CcSEcCtD
Rifabutin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000515	0.00155	CcSEcCtD
Rifabutin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000513	0.00155	CcSEcCtD
Rifabutin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000513	0.00155	CcSEcCtD
Rifabutin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000511	0.00154	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00051	0.00329	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.00051	0.00329	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.00051	0.00329	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00051	0.00154	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000509	0.00154	CcSEcCtD
Rifabutin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000508	0.00153	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000507	0.00153	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PTPN11—peripheral nervous system neoplasm	0.000503	0.00325	CbGpPWpGaD
Rifabutin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000503	0.00152	CcSEcCtD
Rifabutin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000502	0.00151	CcSEcCtD
Rifabutin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.0005	0.00151	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000499	0.0015	CcSEcCtD
Rifabutin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000494	0.00149	CcSEcCtD
Rifabutin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000494	0.00149	CcSEcCtD
Rifabutin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000492	0.00149	CcSEcCtD
Rifabutin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000492	0.00149	CcSEcCtD
Rifabutin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000488	0.00147	CcSEcCtD
Rifabutin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000484	0.00146	CcSEcCtD
Rifabutin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000484	0.00146	CcSEcCtD
Rifabutin—Rash—Topotecan—peripheral nervous system neoplasm	0.000484	0.00146	CcSEcCtD
Rifabutin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000484	0.00146	CcSEcCtD
Rifabutin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000484	0.00146	CcSEcCtD
Rifabutin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000482	0.00145	CcSEcCtD
Rifabutin—Headache—Topotecan—peripheral nervous system neoplasm	0.000481	0.00145	CcSEcCtD
Rifabutin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00048	0.00145	CcSEcCtD
Rifabutin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00048	0.00145	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00048	0.00145	CcSEcCtD
Rifabutin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00048	0.00145	CcSEcCtD
Rifabutin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00048	0.00145	CcSEcCtD
Rifabutin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000479	0.00144	CcSEcCtD
Rifabutin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000478	0.00144	CcSEcCtD
Rifabutin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000478	0.00144	CcSEcCtD
Rifabutin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000477	0.00144	CcSEcCtD
Rifabutin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000477	0.00144	CcSEcCtD
Rifabutin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000476	0.00144	CcSEcCtD
Rifabutin—Pain—Vincristine—peripheral nervous system neoplasm	0.000476	0.00144	CcSEcCtD
Rifabutin—Rash—Melphalan—peripheral nervous system neoplasm	0.000474	0.00143	CcSEcCtD
Rifabutin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000474	0.00143	CcSEcCtD
Rifabutin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.00142	CcSEcCtD
Rifabutin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00047	0.00142	CcSEcCtD
Rifabutin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000469	0.00141	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000467	0.00141	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000463	0.0014	CcSEcCtD
Rifabutin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000462	0.00298	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	0.000461	0.00298	CbGpPWpGaD
Rifabutin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000459	0.00138	CcSEcCtD
Rifabutin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00138	CcSEcCtD
Rifabutin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00138	CcSEcCtD
Rifabutin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000456	0.00138	CcSEcCtD
Rifabutin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000455	0.00137	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—AKT1—peripheral nervous system neoplasm	0.000455	0.00294	CbGpPWpGaD
Rifabutin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000455	0.00137	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000454	0.00293	CbGpPWpGaD
Rifabutin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000453	0.00137	CcSEcCtD
Rifabutin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000453	0.00137	CcSEcCtD
Rifabutin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000453	0.00137	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000449	0.0029	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000449	0.0029	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000448	0.00135	CcSEcCtD
Rifabutin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000447	0.00135	CcSEcCtD
Rifabutin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000447	0.00135	CcSEcCtD
Rifabutin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000442	0.00133	CcSEcCtD
Rifabutin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000441	0.00133	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00133	CcSEcCtD
Rifabutin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00044	0.00133	CcSEcCtD
Rifabutin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00044	0.00133	CcSEcCtD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00044	0.00284	CbGpPWpGaD
Rifabutin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000439	0.00132	CcSEcCtD
Rifabutin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000438	0.00132	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.000436	0.00282	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	0.000435	0.00281	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—ERBB2—peripheral nervous system neoplasm	0.000433	0.00279	CbGpPWpGaD
Rifabutin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00043	0.0013	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.00129	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—peripheral nervous system neoplasm	0.000428	0.00276	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.000428	0.00276	CbGpPWpGaD
Rifabutin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000428	0.00129	CcSEcCtD
Rifabutin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000426	0.00129	CcSEcCtD
Rifabutin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00128	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000425	0.00128	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000422	0.00127	CcSEcCtD
Rifabutin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000421	0.00127	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00127	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000416	0.00125	CcSEcCtD
Rifabutin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00125	CcSEcCtD
Rifabutin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00041	0.00124	CcSEcCtD
Rifabutin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.00123	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HGF—peripheral nervous system neoplasm	0.000407	0.00263	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD55—peripheral nervous system neoplasm	0.000407	0.00263	CbGpPWpGaD
Rifabutin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.00123	CcSEcCtD
Rifabutin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000405	0.00122	CcSEcCtD
Rifabutin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000405	0.00122	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000403	0.0026	CbGpPWpGaD
Rifabutin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000402	0.00121	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000402	0.00259	CbGpPWpGaD
Rifabutin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000399	0.0012	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—peripheral nervous system neoplasm	0.000398	0.00257	CbGpPWpGaD
Rifabutin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000396	0.00119	CcSEcCtD
Rifabutin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00119	CcSEcCtD
Rifabutin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000393	0.00118	CcSEcCtD
Rifabutin—HSP90AA1—Disease—GNS—peripheral nervous system neoplasm	0.000392	0.00253	CbGpPWpGaD
Rifabutin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000392	0.00118	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00118	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000389	0.00117	CcSEcCtD
Rifabutin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000389	0.00117	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000386	0.00116	CcSEcCtD
Rifabutin—Pain—Etoposide—peripheral nervous system neoplasm	0.000385	0.00116	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.00116	CcSEcCtD
Rifabutin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000381	0.00115	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000381	0.00246	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000375	0.00113	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000374	0.00241	CbGpPWpGaD
Rifabutin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000371	0.00112	CcSEcCtD
Rifabutin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00037	0.00112	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00112	CcSEcCtD
Rifabutin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000369	0.00111	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000368	0.00238	CbGpPWpGaD
Rifabutin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.00111	CcSEcCtD
Rifabutin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000364	0.0011	CcSEcCtD
Rifabutin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000364	0.0011	CcSEcCtD
Rifabutin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000363	0.00109	CcSEcCtD
Rifabutin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00109	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000359	0.00232	CbGpPWpGaD
Rifabutin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.00108	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000356	0.00107	CcSEcCtD
Rifabutin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000356	0.00107	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000356	0.00107	CcSEcCtD
Rifabutin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000354	0.00107	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000354	0.00228	CbGpPWpGaD
Rifabutin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000353	0.00106	CcSEcCtD
Rifabutin—Rash—Vincristine—peripheral nervous system neoplasm	0.000351	0.00106	CcSEcCtD
Rifabutin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000351	0.00106	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00105	CcSEcCtD
Rifabutin—Headache—Vincristine—peripheral nervous system neoplasm	0.000349	0.00105	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00105	CcSEcCtD
Rifabutin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.00103	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00103	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—MET—peripheral nervous system neoplasm	0.000342	0.00221	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	0.000337	0.00218	CbGpPWpGaD
Rifabutin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00102	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000336	0.00217	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000336	0.00217	CbGpPWpGaD
Rifabutin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000332	0.001	CcSEcCtD
Rifabutin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000332	0.001	CcSEcCtD
Rifabutin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000331	0.000997	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000329	0.00212	CbGpPWpGaD
Rifabutin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000993	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—GNS—peripheral nervous system neoplasm	0.000328	0.00212	CbGpPWpGaD
Rifabutin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000323	0.000976	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000975	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000969	CcSEcCtD
Rifabutin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000319	0.000962	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	0.000318	0.00205	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000316	0.00204	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NME1—peripheral nervous system neoplasm	0.000315	0.00203	CbGpPWpGaD
Rifabutin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000313	0.000944	CcSEcCtD
Rifabutin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000936	CcSEcCtD
Rifabutin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000935	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD34—peripheral nervous system neoplasm	0.000309	0.00199	CbGpPWpGaD
Rifabutin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000308	0.00093	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.000308	0.00199	CbGpPWpGaD
Rifabutin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000928	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000307	0.00198	CbGpPWpGaD
Rifabutin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00092	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000915	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—COX2—peripheral nervous system neoplasm	0.000303	0.00196	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000303	0.00195	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	0.000298	0.00192	CbGpPWpGaD
Rifabutin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000897	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000297	0.00192	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PTPN11—peripheral nervous system neoplasm	0.000297	0.00192	CbGpPWpGaD
Rifabutin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000292	0.000882	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000291	0.00188	CbGpPWpGaD
Rifabutin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000287	0.000865	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000863	CcSEcCtD
Rifabutin—Rash—Etoposide—peripheral nervous system neoplasm	0.000284	0.000857	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000284	0.000857	CcSEcCtD
Rifabutin—Headache—Etoposide—peripheral nervous system neoplasm	0.000282	0.000852	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000852	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	0.000281	0.00181	CbGpPWpGaD
Rifabutin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000846	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000836	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000275	0.00177	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000274	0.00177	CbGpPWpGaD
Rifabutin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000809	CcSEcCtD
Rifabutin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000268	0.000808	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000799	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000795	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000795	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000795	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000263	0.0017	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NCAM1—peripheral nervous system neoplasm	0.000262	0.00169	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00079	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.00026	0.00168	CbGpPWpGaD
Rifabutin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000774	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000769	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00025	0.00161	CbGpPWpGaD
Rifabutin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00075	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000749	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000746	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00074	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000736	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000736	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000736	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—MET—peripheral nervous system neoplasm	0.000244	0.00157	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000731	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000727	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000241	0.00155	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ENO2—peripheral nervous system neoplasm	0.000238	0.00153	CbGpPWpGaD
Rifabutin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000711	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ERBB2—peripheral nervous system neoplasm	0.000235	0.00152	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000694	CcSEcCtD
Rifabutin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000694	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000691	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000689	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000685	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000684	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000225	0.00146	CbGpPWpGaD
Rifabutin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00068	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000224	0.00145	CbGpPWpGaD
Rifabutin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000672	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000671	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000221	0.00143	CbGpPWpGaD
Rifabutin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000663	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000658	CcSEcCtD
Rifabutin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000652	CcSEcCtD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000215	0.00138	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000643	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000213	0.00137	CbGpPWpGaD
Rifabutin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000638	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000633	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000629	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000628	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000208	0.00134	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000623	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IFNB1—peripheral nervous system neoplasm	0.000206	0.00133	CbGpPWpGaD
Rifabutin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000621	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000613	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000609	CcSEcCtD
Rifabutin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000603	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000603	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000603	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000199	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000199	0.00128	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000198	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000196	0.00126	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000193	0.00125	CbGpPWpGaD
Rifabutin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000581	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000192	0.00124	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000192	0.00124	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000577	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.00019	0.00123	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00019	0.00123	CbGpPWpGaD
Rifabutin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000562	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000558	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000558	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000547	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000539	CcSEcCtD
Rifabutin—HSP90B1—Immune System—NRAS—peripheral nervous system neoplasm	0.000179	0.00115	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000178	0.00115	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000177	0.00115	CbGpPWpGaD
Rifabutin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000522	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000173	0.00111	CbGpPWpGaD
Rifabutin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00052	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	0.000171	0.00111	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000168	0.00109	CbGpPWpGaD
Rifabutin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000506	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000499	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000485	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00016	0.00104	CbGpPWpGaD
Rifabutin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000483	CcSEcCtD
Rifabutin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000481	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00048	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HGF—peripheral nervous system neoplasm	0.000159	0.00103	CbGpPWpGaD
Rifabutin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000478	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—TH—peripheral nervous system neoplasm	0.000158	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000157	0.00102	CbGpPWpGaD
Rifabutin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000453	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000448	CcSEcCtD
Rifabutin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000445	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000444	CcSEcCtD
Rifabutin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000442	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000144	0.000931	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000141	0.000913	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000139	0.0009	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000139	0.000897	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000419	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000136	0.000875	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000131	0.000844	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—peripheral nervous system neoplasm	0.000131	0.000844	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000129	0.000833	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000127	0.000817	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000123	0.000797	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.00012	0.000773	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000118	0.000759	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—peripheral nervous system neoplasm	0.000117	0.000755	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTPN11—peripheral nervous system neoplasm	0.000116	0.000749	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—peripheral nervous system neoplasm	0.000115	0.000745	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000109	0.000705	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000108	0.000697	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTPN11—peripheral nervous system neoplasm	0.000107	0.000691	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.92e-05	0.00064	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—peripheral nervous system neoplasm	9.6e-05	0.00062	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.56e-05	0.000617	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—peripheral nervous system neoplasm	9.17e-05	0.000592	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.76e-05	0.000565	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.76e-05	0.000565	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—peripheral nervous system neoplasm	8.46e-05	0.000546	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.94e-05	0.000513	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.73e-05	0.000499	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.5e-05	0.000484	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.37e-05	0.000476	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—peripheral nervous system neoplasm	6.97e-05	0.00045	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	6.91e-05	0.000446	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	6.62e-05	0.000428	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—peripheral nervous system neoplasm	6.44e-05	0.000416	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	6.38e-05	0.000412	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—peripheral nervous system neoplasm	6e-05	0.000387	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.93e-05	0.000383	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.38e-05	0.000347	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.33e-05	0.000344	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.11e-05	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—peripheral nervous system neoplasm	5.1e-05	0.000329	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.92e-05	0.000318	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—peripheral nervous system neoplasm	4.71e-05	0.000304	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.51e-05	0.000291	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—peripheral nervous system neoplasm	4.51e-05	0.000291	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.2e-05	0.000271	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.19e-05	0.00027	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—peripheral nervous system neoplasm	4.16e-05	0.000268	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.54e-05	0.000228	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—peripheral nervous system neoplasm	3.48e-05	0.000225	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.45e-05	0.000223	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.37e-05	0.000218	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.33e-05	0.000215	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.3e-05	0.000213	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.23e-05	0.000209	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.91e-05	0.000188	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.73e-05	0.000176	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.71e-05	0.000175	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.66e-05	0.000172	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.6e-05	0.000168	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.57e-05	0.000166	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.09e-05	0.000135	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.06e-05	0.000133	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	7.33e-06	4.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.65e-06	3.65e-05	CbGpPWpGaD
